ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+20.49%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$272M
AUM Growth
+$272M
Cap. Flow
+$41.7M
Cap. Flow %
15.31%
Top 10 Hldgs %
92.71%
Holding
16
New
2
Increased
7
Reduced
–
Closed
2

Top Buys

1
BPMC
Blueprint Medicines
BPMC
$24.6M
2
RGNX icon
Regenxbio
RGNX
$10.3M
3
ARGX icon
argenx
ARGX
$8.06M
4
QURE icon
uniQure
QURE
$8M
5
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$5.52M

Top Sells

1
XENE icon
Xenon Pharmaceuticals
XENE
$17M
2
MRUS icon
Merus
MRUS
$9.32M

Sector Composition

1 Healthcare 86.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$36.9M 7.45% 1,454,686 +217,307 +18% +$5.52M
ANAB icon
2
AnaptysBio
ANAB
$569M
$35.5M 7.17% 1,590,733 +151,654 +11% +$3.39M
QURE icon
3
uniQure
QURE
$896M
$30.6M 6.18% 679,620 +177,645 +35% +$8M
SPRO icon
4
Spero Therapeutics
SPRO
$116M
$26.3M 5.3% 1,943,081 +124,941 +7% +$1.69M
BPMC
5
DELISTED
Blueprint Medicines
BPMC
$24.6M 4.95% +315,029 New +$24.6M
ARWR icon
6
Arrowhead Research
ARWR
$3.05B
$24.3M 4.91% 563,291 +126,777 +29% +$5.48M
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$21.6M 4.36% 1,095,184 +48,000 +5% +$948K
RGNX icon
8
Regenxbio
RGNX
$451M
$20.4M 4.11% 553,453 +280,242 +103% +$10.3M
PVLA
9
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$17.3M 3.49% 5,575,530 – –
PRQR icon
10
ProQR Therapeutics
PRQR
$237M
$14.6M 2.94% 2,401,570 – –
GLPG icon
11
Galapagos
GLPG
$2.07B
$8.73M 1.76% 44,234 – –
ARGX icon
12
argenx
ARGX
$43.6B
$8.06M 1.63% +35,800 New +$8.06M
MOR
13
DELISTED
MorphoSys AG American Depositary Shares
MOR
$3.04M 0.61% 95,898 – –
MRUS icon
14
Merus
MRUS
$4.98B
– – -770,183 Closed -$9.32M
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.07B
– – 0 – –
XENE icon
16
Xenon Pharmaceuticals
XENE
$2.98B
– – -1,499,970 Closed -$17M